About Mark Sylvester
Form D filings for Genome Medical Holding in 2024 list Mark Sylvester as executive officer.
Mark Sylvester first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Sylvester in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Sylvester works with at each company, as listed on that company's latest Form D.
Genome Medical Holding Co · Form D, Sep 23, 2024
JD
Jill Davies
Chief Executive Officer and director
SR
Shaun Rodriguez
Director
EM
Elizabeth Moreno
Executive officer
AP
Alex Parker
Director
RG
Russell Glass
Director